In fact, our prior studies have demonstrated that human TTR-overexpressing transgenic mice manifest a robust deposition of TTR aggregates in the placenta and PE-like features, including hypertension, proteinuria, and the release of anti-angiogenic factors [15]. This evidence concerns the gene TTR and hypertensive disorder.